Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Aran B. Merati"'
Autor:
Dhananjaya Pal, Guillermo A. Morales, Alok R. Singh, Tatiana G. Kutateladze, Adam M. Burgoyne, Kendra R. Vann, Donald L. Durden, Francisco M. Vega, Shweta Joshi, Aran B. Merati
Publikováno v:
Cell Discovery
Cell Discovery, Vol 6, Iss 1, Pp 1-4 (2020)
Digital.CSIC. Repositorio Institucional del CSIC
instname
idUS: Depósito de Investigación de la Universidad de Sevilla
Universidad de Sevilla (US)
idUS. Depósito de Investigación de la Universidad de Sevilla
Cell Discovery, Vol 6, Iss 1, Pp 1-4 (2020)
Digital.CSIC. Repositorio Institucional del CSIC
instname
idUS: Depósito de Investigación de la Universidad de Sevilla
Universidad de Sevilla (US)
idUS. Depósito de Investigación de la Universidad de Sevilla
The PI3K-AKT-mTOR pathway has been at the center of anti-cancer drug development1,2, but targeted inhibition of PI3K kinase activity is proven to provide a limited therapeutic effect and is often followed by the development of resistance to the drug3
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7908c1a6f1c38b97a92dc063ea2aa725
http://hdl.handle.net/10261/238737
http://hdl.handle.net/10261/238737
Autor:
Steven L. Gonias, Karra A. Jones, Andrew S. Gilder, Na Du, Michael A. Banki, Scott R. VandenBerg, Donald P. Pizzo, Michael S. Lam, Aran B. Merati
Publikováno v:
Neuro-oncology, vol 18, iss 5
Author(s): Jones, Karra A; Gilder, Andrew S; Lam, Michael S; Du, Na; Banki, Michael A; Merati, Aran; Pizzo, Donald P; VandenBerg, Scott R; Gonias, Steven L | Abstract: BackgroundIn glioblastoma (GBM), the gene for epidermal growth factor receptor (EG
Autor:
Burgoyne, Adam M., Vann, Kendra R., Joshi, Shweta, Morales, Guillermo A., Vega, Francisco M., Singh, Alok, Pal, Dhananjaya, Merati, Aran B., Kutateladze, Tatiana G., Durden, Donald L.
Publikováno v:
Cell Discovery; 7/28/2020, Vol. 6 Issue 1, p1-4, 4p